<DOC>
	<DOCNO>NCT00166855</DOCNO>
	<brief_summary>Background : Multiple myeloma ( MM ) clonal plasma cell neoplasm characterize proliferation neoplastic plasma cell bone marrow ( BM ) . So far , incurable disease median survival time MM patient three four year . Till , whether extent angiogenesis BM MM patient serve important independent prognostic factor still debate . In study , would like BM perfusion status image dynamic MRI mimic macroscopic vascular density BM , thereafter , BM perfusion status , clinical outcome MM patient , angiogenesis related biological marker correlate . Methods : About 35 50 MM patient , include newly diagnose patient patient undertake special treatment , enrol study . The thoraco-lumbar spine scan MRI , BM perfusion status obtain contrast-enhanced dynamic MRI . Meanwhile , patient undertake BM biopsy one site two site BM aspirate also obtain separate BM plasma BM mononuclear cell ( BMMC ) Ficoll-Hypaque centrifugation . The angiogenesis relate gene expression profile BMMC determine cDNA microarrays , like VEGF , bFGF , PDGF , semiquantified real-time PCR . The level relate protein determine ELISA . The BM plasma sample apply proteomic analysis screen novel molecule clinical relevance . Prospects : BM perfusion pattern image dynamic MRI predict clinical outcome MM , correlate angiogenesis relevant biological marker BM .</brief_summary>
	<brief_title>Clinical Implication Bone Marrow Perfusion Patterns Imaged Dynamic MRI Multiple Myeloma</brief_title>
	<detailed_description>Multiple myeloma ( MM ) clonal plasma cell neoplasm characterize proliferation abnormal plasma cell bone marrow ( BM ) secrete monoclonal paraprotein ( M-protein ) serum and/or urine , osteolytic bone destruction . So far , incurable disease pathogenesis largely unknown . The median survival time MM patient three four year , patient die either disease complication [ Barlogie et al , 2004 ] . There several independent prognostic factor MM , like high level beta-2 microglobulin , hypodiploidy chromosome content , deletion chromosome 13q14 also extent angiogenesis , show microvascular density ( MVD ) , BM [ Fonseca et al , 2004 ; Kumar et al , 2002 ; Pruneri et al , 2002 ; Sezer et al , 2000 ] . It suggest MM progress avascular vascular phase ( active MM ) accompany significant increase MVD BM [ Rajkumar et al , 2002 ] , promote angiogenesis related factor , like VEGF , bFGF , PDGF , perform like paracrine autocrine loop secrete MM cell per se adjacent BM stromal cell [ Gupta et al , 2001 ; Kumar et al , 2003 ; Ria et al , 2003 ; Vacca et al , 2003 ] . It report high MVD BM time initial diagnosis associate short OS PFS patient undergo autologous transplantation MM patient low MVD [ Kumar et al , 2004 ] . Those angiogenesis related factor may provide disease monitoring also potent novel therapeutic approach come resistance therapy thereby improve patient outcome [ Podar et al , 2004 ] . Interestingly , patient deletion chromosome 13q14 high MVD BM patient without [ Schreiber 2000 ] , hint grave prognosis deletion chromosome 13q14 might result dysregulation angiogenesis BM . However , hand , absence clinical prognostic value VEGF MVD MM also report investigator [ Ahn et al , 2001 ; Choi et al , 2002 ] . In MM , whether MVD BM relate biological marker , like VEGF , bFGF , PDGF serve prognostic factor still debate [ Rajkumar et al , 2001 ; Vacca et al , 2001 ] . There possible two reason debate , first one distribution neoplastic focus within BM MM homogenous , therefore microvascular density calculate single site BM specimen hard represent total angiogenesis within BM ; second one angiogenesis related biological marker , VEGF , bFGF , PDGF , MM largely study plasma obtain peripheral blood rather BM , critical issue cytokine secrete either MM cell adjacent stromal cell mostly paracrines autocrines level VEGF , bFGF , PDGF high BM peripheral blood [ Di Raimondo et al , 2000 ] . Reviewing literature , dynamic contrast-enhanced MRI use evaluate potential vertebral fracture MM [ Scherer et al , 2002a &amp; 2002b ] , quantify significant change BM microcirculation conventional treatment [ Rahmouni et al , 1993 ] treatment thalidomide combine chemotherapy [ Wasser et al , 2004 ] , may novel non-invasive tool approach clinical outcome MM patient [ Moehler et al , 2001 ] . In short , MR image spine perform 1.5-T superconducting system ( Magnetom Vision Plus ; Siemens , Erlangen , Germany ) . A phase-array spine-coil use , routine fast spin-echo T1-weighted sequence ( repletion time msec/echo time msec , 600/12 ; turbo factor three ; section thickness , 4 mm ; field view , 28cm ) perform midsagittal plane cover area T11 sacrum . A dynamic contrast-enhanced MR study perform ( section thickness , 10 mm ; field view , 28 cm ) midsection vertebral body cover area . The pulse sequence use turbo fast low-grade shot gradient-echo sequence ( 8.5/4.0 ; prepulse inversion time , 160 msec ; flip angle , 10° ; acquisition matrix , 72x128 ) . Acquisition time 0.89 second 0.11-second delay . In total , 100 dynamic image obtain within 100 second ( one frame per second ) subject . After initial 100-second scanning , scan prolong 600 second scan rate 1 frame per 10 second ( 1 second scan 9 second delay ) . An injection 0.1 mmol per kilogram body weight gadopentetate dimeglumine ( Magnevist ; Schering , Berlin , Germany ) administrate power injector 21-gauge intravenous catheter insert right antecubital vein previously . A brief constant injection rate 2.0ml/sec use . This injection immediately follow 20-ml saline flush injection rate . Dynamic imaging start injection contrast material commence . Signal intensity value measure operator-defined region interest ( ROIs ) . The musculoskeletal radiologist ( T.T.F.S. , 15 year experience ) place ROIs place aid cursor graphic display device , along border high-signal-intensity bone marrow T1 weight image cover entire bone marrow vertebra . One vertebral body cover one ROI measurement . The ROI measure separately select lumbar vertebra ( L2 , L3 L4 ) subject . The signal intensity value derive ROI measure vertebral body plot time obtain time–signal intensity curve ( Fig 1 ) vertebral body . The baseline value signal intensity ( SIbase ) time– signal intensity curve define mean signal intensity first three image . The maximum signal intensity ( SImax ) define maximum value first rapidly rise part time–signal intensity curve . The time peak contrast enhancement define time ( Trise ) SIbase SImax . After peak , usually occur 40 second start injection , time–signal intensity curve enter equilibrium phase last 30 second . The total 100-second imaging time encompass first rapid rise curve early equilibrium phase . In study , SIbase SImax measure first rapidly rise curve . For semiquantitative analysis , peak enhancement ratio peak calculate ROI ( SImax – SIbase ) /SIbase average enhancement slope ( average slope ) define ( SImax – SIbase ) / Trise ROI . The initial slope measure steep uprising slope early rapid-rising part time intensity curve . The mean value calculate parameter L3 , L3 L4 vertebra represent subject . In preliminary study , like others [ Moehler et al , 2001 ] , construct image perform dynamic contrast-enhanced MRI , mimic perfusion status within bone marrow , correlate distinct clinical outcome acute myeloid leukemia MM patient preliminary study . Accordingly , would like BM perfusion status image dynamic MRI mimic macroscopic vascular density BM , thereafter , BM perfusion status , clinical outcome MM patient , angiogenesis related biological marker correlate .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>multiple myeloma , newly diagnose nil , except patient disagree MRI study bone marrow sample</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2005</verification_date>
	<keyword>angiogenesis</keyword>
	<keyword>bone marrow perfusion</keyword>
	<keyword>dynamic MRI</keyword>
	<keyword>multiple myeloma</keyword>
	<keyword>prognosis</keyword>
</DOC>